Raymond James & Associates »

Aldeyra Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $118k 36k 3.27
2023-12-31 $115k 33k 3.51
2023-09-30 $341k 51k 6.68
2023-06-30 $435k 52k 8.39
2023-03-31 $267k 27k 9.93
2022-12-31 $179k 26k 6.96
2022-09-30 $144k 27k 5.32
2022-06-30 $125k 31k 4.00
2022-03-31 $117k 26k 4.45
2021-12-31 $87k 22k 4.01
2021-09-30 $403k 46k 8.79
2021-06-30 $525k 46k 11.33
2021-03-31 $265k 22k 11.88
2020-12-31 $156k 23k 6.84
2020-09-30 $169k 23k 7.41
2020-06-30 $92k 22k 4.16
2020-03-31 $61k 25k 2.48
2019-12-31 $131k 23k 5.80
2019-09-30 $117k 22k 5.27
2019-06-30 $103k 17k 6.02